Heather Han - Concepedia

Author

Heather Han

Moffitt Cancer Center

Also Known As

Erin D. Ellis, H. Han, H.S. Han, Heather Han, Heather S Han, Heather S. Han, HyoS Han, Kathleen A. Kemmer

Publications

783

Citations

H-Index

Concepts

All Affiliations

Moffitt Cancer Center University of Alabama at Birmingham The University of Texas MD Anderson Cancer Center University of California, San Francisco UPMC Hillman Cancer Center

About

Heather Han is an author at Moffitt Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	697
2	Immunology	2	2	221
3	Obstetrics	2	2	51
4	Education	1	1	192
5	Health Sciences	1	1	208

Heather Han

Publications

697

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2. Rita Nanda, Minetta C. Liu, Christina Yau, Journal of Clinical Oncology Breast OncologyHigh-risk Breast CancerImmunologyPharmacotherapyImmunotherapeutics	2017	208
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study Heather Han, Véronique Dièras, Mark E. Robson, Annals of Oncology Carboplatin/paclitaxel Versus PlaceboBreast OncologyRecurrent/metastatic Breast CancerMedicinePharmacology	2017	201
Mindfulness-Based Stress Reduction in Post-treatment Breast Cancer Patients: Immediate and Sustained Effects Across Multiple Symptom Clusters Richard R. Reich, Cecile A. Lengacher, Carissa B. Alinat, Journal of Pain and Symptom Management PsychiatryMeditationMindfulness-based Stress ReductionPsychologyEducation	2016	192
Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience Nicholas Figura, Wendy Long, Michael Yu, Breast Cancer Research and Treatment Single Institution ExperienceIntrathecal TrastuzumabGynecologyBreast CancerBreast Surgery	2018	36
Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer Véronique Dièras, Heather Han, Bella Kaufman, Annals of Oncology Breast OncologyOncologyMedicineBreast CancerAnti-cancer Agent	2019	32
Phase Ib study of gedatolisib in combination with palbociclib and endocrine therapy (ET) in women with estrogen receptor (ER) positive (+) metastatic breast cancer (MBC) (B2151009). Andres Forero‐Torres, Heather Han, Elizabeth Claire Dees, Journal of Clinical Oncology Breast OncologyEstrogen ReceptorGynecologyPharmacotherapyTumor Biology	2018	15
Abstract PD1-10: Evaluation of SGN-LIV1a followed by AC in high-risk HER2 negative stage II/III breast cancer: Results from the I-SPY 2 TRIAL Heather Beckwith, Richard J. Schwab, Christina Yau, Cancer Research Tumor BiologyBreast OncologyMedicineMetronomic TherapyImmunology	2021	13

Page 1